DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $61,596,000 | +8.3% | 1,812,710 | +16.7% | 0.48% | +12.6% |
| Q2 2021 | $56,866,000 | -21.3% | 1,553,283 | -3.6% | 0.43% | -20.7% |
| Q1 2021 | $72,223,000 | -18.4% | 1,610,683 | +3.9% | 0.54% | -21.3% |
| Q4 2020 | $88,487,000 | +12.0% | 1,550,500 | +0.7% | 0.69% | -8.9% |
| Q3 2020 | $79,013,000 | -15.7% | 1,540,218 | -1.8% | 0.75% | -22.2% |
| Q2 2020 | $93,681,000 | +35.1% | 1,568,669 | -6.9% | 0.97% | +6.3% |
| Q1 2020 | $69,355,000 | -34.2% | 1,684,594 | -0.5% | 0.91% | -2.8% |
| Q4 2019 | $105,388,000 | +76.4% | 1,693,256 | -3.8% | 0.94% | +57.2% |
| Q3 2019 | $59,729,000 | +386.6% | 1,759,850 | +223.3% | 0.60% | +405.1% |
| Q2 2019 | $12,274,000 | +34.2% | 544,297 | +38.2% | 0.12% | +37.2% |
| Q1 2019 | $9,143,000 | +22.4% | 393,932 | +10.7% | 0.09% | +10.3% |
| Q4 2018 | $7,472,000 | -41.7% | 355,957 | +7.5% | 0.08% | -27.1% |
| Q3 2018 | $12,816,000 | +3.6% | 330,990 | +5.3% | 0.11% | -6.1% |
| Q2 2018 | $12,372,000 | +135.5% | 314,397 | +35.7% | 0.11% | +115.1% |
| Q4 2017 | $5,254,000 | +37.5% | 231,760 | +15.1% | 0.05% | +23.3% |
| Q3 2017 | $3,822,000 | – | 201,285 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |